50 semaglutide Oral mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial VisualAbstract:Oral semaglutide effectively reduces bodyweight

This pricing covers the medication itself

Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior weight loss and expanded therapeutic applications spanning from brain health to renal disease". For 2026, pharma executives must recognize that metabolic innovation extends far beyond replicating existing GLP-1 therapies, the report authors wrote

142 In a randomized placebo-controlled trial in 78 PCOS patients, 1,000 mg resveratrol daily for three months resulted in increased menstrual regularity and reduced hair loss, though other reproductive and metabolic indices were unchanged

1